Treatment with tirzepatide demonstrated a 38% decrease in the risk of heart failure outcomes (composite endpoint) compared with placebo. Detailed results were announced from the phase 3 SUMMIT trial ...

Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women.

Statistics from 2023 on U.S. obesity rates reveal that in every U.S. state, one in every five people now has obesity.

HeartFlow’s AI-enabled plaque quantification technology has been upgraded to a new I CPT category code by the American Medical Association.

Tryvio (aprocitentan) is now available for difficult-to-control hypertension in combination with other antihypertensive drugs.

People with a late chronotype have an increased risk for T2D and have higher body mass index (BMI) and larger waist circumference.

A study was conducted to determine the effect of poor childhood oral health on risk for MI, ischemic stroke, and ischemic ...

A study was conducted to determine the association between housing unaffordability and health outcomes and medication ...

Researchers sought to determine if there is an association between attendance in cardiac rehabilitation and the prevalence ...

Researchers sought to determine the relationship between sleep duration and clinical depression in patients with cardiovascular disease.

Among patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor use was linked to reduced risk for neurodegenerative disorders. Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is ...

HealthDay News — The global prevalence of congenital heart disease (CHD) at high altitude is 8.97 percent, according to the results of a review presented at the American College of Cardiology Latin ...